Background
Juvenile myelomonocytic leukaemia (JMML) is a rare myeloproliferative neoplasm of early childhood driven by RAS-MAPK pathway activation, for which allogeneic haematopoietic stem cell transplantation (HSCT) is the only established cure. Data from low- and middle-income countries, where donor access, drug avai...
Amitabh Singh, R. Majhi, A. Gupta et al.· Frontiers in Oncology· 0 citations
Background B cells play a critical role in autoimmunity through autoantibody production, plasma cell differentiation, antigen presentation, cytokine secretion, and germinal center responses. The clinical efficacy, durability, and safety profiles vary across autoimmune diseases. Therefore, the objective is to assess B-c...
Vishakha Hooda, Harsh Goel, Taruna Madan et al.· Frontiers in Immunology· 0 citations
Background/Objectives: Juvenile myelomonocytic leukemia (JMML) is a rare and very aggressive pediatric myelodysplastic/myeloproliferative neoplasm with molecular heterogeneity and constitutive activation of the RAS signaling pathway. The aim of this study was to identify the mutational landscape, driver genes, mutation...
Harsh Goel, R. Majhi, J. Meena et al.· Medical Science· 0 citations
This study provides a comprehensive characterization of epigenetic regulator gene alterations in JMML and highlights the importance of epigenetic dysregulation in disease pathogenesis.
Harsh Goel, R. Majhi, J. Meena et al.· Epigenomes· 1 citation
Distinct molecular subtypes of breast cancer among Indian women exhibit heterogeneous risk profiles shaped by reproductive, lifestyle, and psychosocial factors, which underscores the need for targeted public health strategies focusing on modifiable risk factors.
P. George, Aleyamma Mathew, T. Kaur et al.· Breast Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.